Cargando…
CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I
Increased ribosome biogenesis is a distinguishing feature of cancer cells, and small molecule inhibitors of ribosome biogenesis are currently in clinical trials as single agent therapy. It has been previously shown that inhibiting ribosome biogenesis through the inhibition of nuclear export of ribos...
Autores principales: | Lehman, Stacey L., Schwartz, Kayla R., Maheshwari, Shrankhla, Camphausen, Kevin, Tofilon, Philip J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904802/ https://www.ncbi.nlm.nih.gov/pubmed/35260696 http://dx.doi.org/10.1038/s41598-022-07928-4 |
Ejemplares similares
-
Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
por: Lehman, Stacey L., et al.
Publicado: (2021) -
The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma
por: Kang, Chang-Won, et al.
Publicado: (2022) -
rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
por: Son, Jinbae, et al.
Publicado: (2020) -
Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling
por: Quin, Jaclyn, et al.
Publicado: (2016) -
The chemotherapeutic agent CX-5461 irreversibly blocks RNA polymerase I initiation and promoter release to cause nucleolar disruption, DNA damage and cell inviability
por: Mars, Jean-Clément, et al.
Publicado: (2020)